Advertisement

Topics

Biogen Idec and Elan Corporation, plc Company Profile

07:50 EDT 22nd September 2017 | BioPortfolio

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients worldwide benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.


News Articles [389 Associated News Articles listed on BioPortfolio]

Hepatic Safety Of Biogen Idec’s Zinbryta Under Close Scrutiny In EU

The EU review of Biogen Idec’s MS drug Zinbryta is continuing as a special group at the European Medicines Agency...    

Biogen Idec: Jahresprognosen erhöht!

Kommentar von Volker GelfarthLiebe Leser, Biogen ist nach einer beeindruckenden Wachstumsserie in eine Übergangsphase mit moderateren Zuwächsen getreten. Die weltweit führende Marktstellung im 20 M...

Vicarius Pharma Launches With $21.8 Million and Will be Helmed by Former Biogen-Elan Exec

Vicarius Pharma Launches With $21.8 Million and Will be Helmed by Former Biogen-Elan Exec

  Life Sciences Jobs   ...

Adaptive Biotechnologies and Biogen Idec Sign Immunological Services Agreement

SEATTLE, June 27, 2013 /PRNewswire/ -- Adaptive Biotechnologies announced today that it has signed an agreement with Biogen Idec for the study of the immune repertoire and the search for immunological...

wikifolio whispers p.m. zu Fuchs Petrolub, Zumtobel, Biogen Idec ...

Aktuelle Kommentare aus dem wikifolio-Universum. Mit Links zu den jeweiligen Depots, damit man sieht, wie erfolgreich die Kommentatoren mit ihren Einschätzungen sind und wie sich die genannten Inpu.....

Biogen Acquires Remedy Pharmaceuticals' CIRARA™ for Large Hemispheric Stroke

Phase 3-ready program complements Biogen's ongoing development efforts in stroke Biogen will pay a $120 million upfront payment plus potential milestone and royalty payments Biogen (NASDAQ: BIIB) ...

Nasdaq 100 fährt Achterbahn und bei Novartis wendet sich das Blatt (Social Feeds Extended)

Nasdaq 100 fährt Achterbahn >> Bildauswahl durch die BSNgine, zum Originalzusammenhang » Biogen Idec und Gilead Sciences vs.... » SMI® PR und Nasdaq vs. ATX und TECDAX -... Der Aktionär Achterbah...

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Biogen pays Forward in Tecfidera dispute.

Comparative Evaluation of αCD40 (2C10R4) and αCD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model.

Specific blockade of T cell costimulation pathway is a promising immunomodulatory approach being developed to replace our current clinical immunosuppression therapies. The goal of this study is to com...

Leveraging a CHO cell line toolkit to accelerate biotherapeutics into the clinic.

The Biogen upstream platform is capable of delivering equivalent quality material throughout the cell line generation process. This allows us to rapidly deliver high quality biopharmaceuticals to pati...

Clinical Trials [14 Associated Clinical Trials listed on BioPortfolio]

Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma

This is a Phase I/II open-label, dose-escalating study in patients with metastatic colorectal cancer. The objectives of the study are to obtain information on the safety of radiolabeled I...

Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma

The purpose of this study is to determine whether anti-CD80 monoclonal antibody (IDEC-114) is effective in the treatment of follicular B-cell non-Hodgkin's lymphoma. This drug has never b...

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

To determine what side effects and what clinical effect, if any, the administration of this investigational product, IDEC-114 in combination with Rituxan® [Rituxan® as a single agent is ...

ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.

The purpose of this study is to see if we can find a new way to test how certain Multiple Sclerosis (MS) medications work in the body and to better understand how the medicines change cert...

Pregnancy Exposure Registry for AVONEX

This is an observational, exposure-registration and follow-up study, which will be conducted in the United States (US). The AVONEX® Pregnancy Exposure Registry is designed to monitor pre...

Companies [216 Associated Companies listed on BioPortfolio]

Biogen Idec and Elan Corporation, plc

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Biogen Idec Inc.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Elan Corporation, plc

Elan Corporation, plc is a neuroscience-based biotechnology company focused on discovering and developing advanced therapies in neurodegeneration and autoimmune diseases, and real...

Biogen Idec and Abbott

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in ...

Biogen Idec and Portola Pharmaceuticals

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in ...

More Information about "Biogen Idec and Elan Corporation, plc" on BioPortfolio

We have published hundreds of Biogen Idec and Elan Corporation, plc news stories on BioPortfolio along with dozens of Biogen Idec and Elan Corporation, plc Clinical Trials and PubMed Articles about Biogen Idec and Elan Corporation, plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biogen Idec and Elan Corporation, plc Companies in our database. You can also find out about relevant Biogen Idec and Elan Corporation, plc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...


Corporate Database Quicklinks



Searches Linking to this Company Record